Ardevora Asset Management LLP Bristol Myers Squibb CO Transaction History

Ardevora Asset Management LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 24, 2019	SELL	$45.12 - $53.8 $23.4 Million - $27.9 Million	-518,088 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$48.76 - $63.23 $3.03 Million - $3.93 Million	62,200 Added 13.64%	518,088 $26.9 Million
Q3 2018 Oct 30, 2018	SELL	$55.19 - $62.25 $2.59 Million - $2.92 Million	-46,900 Reduced 9.33%	455,888 $28.3 Million
Q2 2018 Jul 30, 2018	BUY	$50.53 - $62.98 $1.9 Million - $2.37 Million	37,688 Added 8.1%	502,788 $27.8 Million
Q1 2018 May 08, 2018	BUY	$59.92 - $68.98 $161,784 - $186,246	2,700 Added 0.58%	465,100 $29.4 Million
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $25.5 Million - $29.5 Million	462,400	462,400 $29.5 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ardevora Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Ardevora Asset Management LLP with notifications on news.